Skip to main content

Revision Bulletins

Revision Bulletins are published in USP–NF Online by the first of each month. Each Revision Bulletin includes a notice that provides the reason for the change and the official date. Monograph names listed before April 1, 2021 contain a combined notice and documentary standard; postings after April 1, 2021 provide separate links for the notice and for the standard content. For more information on the Revision Bulletins and the Accelerated Revision process, see USP's Guideline on the Use of Accelerated Processes for Revisions to USP–NF. Archived Revision Bulletins can be found here.

See the Publication & Comment Schedule section for specific posting and official dates.

New and Updated Revision Bulletins

  • Acetaminophen Extended-Release Tablets Notice and Monograph (posted 30-Sep-2022; official 01-Oct-2022)
  • Lacosamide Tablets Notice and Monograph (posted 30-Sep-2022; official 01-Oct-2022)
  • Mesalamine Extended-Release Capsules Notice and Monograph (posted 30-Sep-2022; official 01-Oct-2022)
  • Nortriptyline Hydrochloride Capsules Notice and Monograph (posted 30-Sep-2022; official 01-Oct-2022)
  • Rifabutin Notice and Monograph (posted 30-Sep-2022; official 01-Oct-2022)
  • Carbamazepine Tablets Notice and Monograph (posted 21-Sep-2022; official 22-Sep-2022)
    • Previously posted as a Pending Monograph Revision
  • Rufinamide Tablets Notice and Monograph (posted 15-Sep-2022; official 16-Sep-2022)
    • Previously posted as a Pending Monograph Revision
  • Prochlorperazine Maleate Tablets Notice and Monograph (posted 06-Sep-2022; official 07-Sep-2022)
    • Previously posted as a Pending Monograph Revision
  • Temozolomide Capsules Notice and Monograph (posted 26-Aug-2022; official 01-Sep-2022)
  • Venlafaxine Hydrochloride Extended-Release Capsules Notice and Monograph (posted 26-Aug-2022; official 01-Sep-2022)
  • Metaxalone Tablets Notice and Monograph (posted 29-Jul-2022; official 01-Aug-2022)
  • Paroxetine Extended-Release Tablets Notice and Monograph (posted 29-Jul-2022; official 01-Aug-2022)
  • Diatrizoate Meglumine and Diatrizoate Sodium Solution Notice and Monograph (posted 19-Jul-2022; official 20-Jul-2022)
    • Previously published as a Pending Revision
  • Digoxin Tablets Notice and Monograph (posted 24-Jun-2022; official 01-Jul-2022)
  • Mexiletine Hydrochloride Capsules Notice and Monograph (posted 24-Jun-2022; official 01-Jul-2022)
  • Mitotane Notice and Monograph (posted 24-Jun-2022; official 01-Aug-2023)
  • Mitotane Tablets Notice and Monograph (posted 24-Jun-2022; official 01-Aug-2023)
  • Terazosin Capsules Notice and Monograph (posted 24-Jun-2022; official 01-Jul-2022)
  • Levetiracetam Tablets Notice and Monograph (posted 15-Jun-2022; official 16-Jun-2022)
    • Previously Published as a Pending Revision

Revision Bulletins

To view Accelerated Revisions by official date, please click here.